Exhibit 10.22
ELEDON PHARMACEUTICALS, INC.
Stock Option Agreement
Granted Under 2020 Long Term Incentive Plan
1
Exhibit 10.22
2
Exhibit 10.22
3
Exhibit 10.22
[Signatures page follow.]
4
Exhibit 10.22
IN WITNESS WHEREOF, the Company has caused this Option to be executed under by its duly authorized officer.
ELEDON PHARMACEUTICALS, INC.
By:
Name: Paul Little
Title: Chief Financial Officer
The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Plan.
PARTICIPANT:
Signature of Participant
Grant Acceptance Date
Print Name of Participant
5